Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Obes Surg ; 33(12): 4137-4146, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37917389

ABSTRACT

Severe malnutrition following one-anastomosis gastric bypass (OAGB) remains a concern. Fifty studies involving 49,991 patients were included in this review. In-hospital treatment for severe malnutrition was needed for 0.9% (n = 446) of patients. Biliopancreatic limb (BPL) length was 150 cm in five (1.1%) patients, > 150 cm in 151 (33.9%), and not reported in 290 (65%) patients. OAGB was revised to normal anatomy in 126 (28.2%), sleeve gastrectomy in 46 (10.3%), Roux-en-Y gastric bypass in 41 (9.2%), and shortening of BPL length in 17 (3.8%) patients. One hundred fifty-one (33.8%) patients responded to treatment; ten (2.2%) did not respond and was not reported in 285 (63.9%) patients. Eight (0.02%) deaths were reported. Standardisation of the OAGB technique along with robust prospective data collection is required to understand this serious problem.


Subject(s)
Gastric Bypass , Malnutrition , Obesity, Morbid , Protein-Energy Malnutrition , Humans , Gastric Bypass/methods , Obesity, Morbid/surgery , Malnutrition/etiology , Malnutrition/surgery , Protein-Energy Malnutrition/etiology , Gastrectomy/methods , Retrospective Studies
3.
Obes Surg ; 33(1): 339-344, 2023 01.
Article in English | MEDLINE | ID: mdl-36418772

ABSTRACT

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are glucose-lowering agents being increasingly used for cardio-renal protection in patients with or without type 2 diabetes (T2DM). This systematic review identified the clinical risk factors and outcomes of diabetic ketoacidosis (DKA) in patients undergoing bariatric and metabolic surgery (BMS) on SGLT2i. We found 12 studies with a total of 16 patients (10 females; mean age of 51 years). Apart from one patient, all patients developed DKA in the post-operative period presenting at a median of 5 days after surgery. Most of the patients were euglycaemic on presentation with DKA. Patients undergoing BMS on SGLT2i are at increased risk of developing DKA that can mimic post-operative surgical complications causing diagnostic dilemmas, especially with the euglycaemic variant, and delaying treatment.


Subject(s)
Bariatric Surgery , Diabetes Mellitus, Type 2 , Diabetic Ketoacidosis , Obesity, Morbid , Sodium-Glucose Transporter 2 Inhibitors , Symporters , Female , Humans , Middle Aged , Diabetic Ketoacidosis/chemically induced , Diabetic Ketoacidosis/diagnosis , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/surgery , Sodium-Glucose Transporter 2 Inhibitors/adverse effects , Obesity, Morbid/surgery , Glucose , Bariatric Surgery/adverse effects , Sodium , Symporters/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...